New Clinical Trial Data in Advanced Melanoma Presented at ASCO 2018: How Will it Change How You Practice?

Sanjiv S. Agarwala, MD

Video Categories: 2018 ASCO Insights and Video Library

Dr Sanjiv Agarwala talks about exciting new results presented at ASCO 2018 in melanoma, including the durability of anti–PD-1 therapy in providing 40% overall survival at 5 years, updates on adjuvant therapy showing superiority of anti–PD-1 over anti–CTLA-4, and new results in combining immunotherapies.

December 12, 2016

The Variability of HR+ Breast Cancer

Sunil Verma, MD, MSEd, FRCPC discusses treatment options for this type of cancer.

July 29, 2015

Precision Medicine’s Impact on Patient Care

Dr. S. Yosuf Zafar provides an overview of the advancement of precision medicine and points out the importance of making sure treatment decisions are in line with the patient’s goals.